Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sherwyn L Schwartz

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Diabetes, Obesity & Metabolism|June 17, 2006
Diabetes and dyslipidaemiaSherwyn L Schwartz
The American Journal of Geriatric Pharmacotherapy|February 22, 2011
Treatment of elderly patients with type 2 diabetes mellitus: a systematic review of the benefits and risks of dipeptidyl peptidase-4 inhibitorsSherwyn L Schwartz
Annals of Medicine|December 3, 2011
Saxagliptin for the treatment of type 2 diabetes mellitus: focus on recent studiesSherwyn L Schwartz
Expert Opinion on Pharmacotherapy|March 25, 2006
Metformin extended release for the treatment of type 2 diabetes mellitusSherwyn L Schwartz, Jacqueline F Wu, Bret Berner
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|March 31, 2010
Improved glycemic control with insulin glargine versus pioglitazone as add-on therapy to sulfonylurea or metformin in patients with uncontrolled type 2 diabetes mellitusLuigi F Meneghini, Louise Traylor, Sherwyn L Schwartz
Journal of Diabetes Science and Technology|November 4, 2009
United States patient preference and usability for the new disposable insulin device Solostar versus other disposable pensJerome S Fischer, Steven V Edelman, Sherwyn L Schwartz
Expert Review of Medical Devices|November 6, 2010
Humalog(®) KwikPen™: an insulin-injecting pen designed for ease of useSherwyn L Schwartz, Debra A Ignaut, Jennifer N Bodie
Diabetes Care|October 27, 2004
Efficacy and safety of inhaled insulin (Exubera) compared with subcutaneous insulin therapy in patients with type 1 diabetes: results of a 6-month, randomized, comparative trialTeresa Quattrin, André Bélanger, Nancy J V Bohannon, et al.
The Diabetes Educator|September 29, 2009
Comparative device assessments: Humalog KwikPen compared with vial and syringe and FlexPenDebra A Ignaut, Sherwyn L Schwartz, Samiha Sarwat, et al.
Diabetes Technology & Therapeutics|August 23, 2011
Safety, pharmacokinetic, and pharmacodynamic profiles of ipragliflozin (ASP1941), a novel and selective inhibitor of sodium-dependent glucose co-transporter 2, in patients with type 2 diabetes mellitusSherwyn L Schwartz, Bola Akinlade, Sally Klasen, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Diabetes, Obesity & Metabolism|June 17, 2006
Diabetes and dyslipidaemiaSherwyn L Schwartz
The American Journal of Geriatric Pharmacotherapy|February 22, 2011
Treatment of elderly patients with type 2 diabetes mellitus: a systematic review of the benefits and risks of dipeptidyl peptidase-4 inhibitorsSherwyn L Schwartz
Annals of Medicine|December 3, 2011
Saxagliptin for the treatment of type 2 diabetes mellitus: focus on recent studiesSherwyn L Schwartz
Expert Opinion on Pharmacotherapy|March 25, 2006
Metformin extended release for the treatment of type 2 diabetes mellitusSherwyn L Schwartz, Jacqueline F Wu, Bret Berner
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|March 31, 2010
Improved glycemic control with insulin glargine versus pioglitazone as add-on therapy to sulfonylurea or metformin in patients with uncontrolled type 2 diabetes mellitusLuigi F Meneghini, Louise Traylor, Sherwyn L Schwartz
Journal of Diabetes Science and Technology|November 4, 2009
United States patient preference and usability for the new disposable insulin device Solostar versus other disposable pensJerome S Fischer, Steven V Edelman, Sherwyn L Schwartz
Expert Review of Medical Devices|November 6, 2010
Humalog(®) KwikPen™: an insulin-injecting pen designed for ease of useSherwyn L Schwartz, Debra A Ignaut, Jennifer N Bodie
Diabetes Care|October 27, 2004
Efficacy and safety of inhaled insulin (Exubera) compared with subcutaneous insulin therapy in patients with type 1 diabetes: results of a 6-month, randomized, comparative trialTeresa Quattrin, André Bélanger, Nancy J V Bohannon, et al.
The Diabetes Educator|September 29, 2009
Comparative device assessments: Humalog KwikPen compared with vial and syringe and FlexPenDebra A Ignaut, Sherwyn L Schwartz, Samiha Sarwat, et al.
Diabetes Technology & Therapeutics|August 23, 2011
Safety, pharmacokinetic, and pharmacodynamic profiles of ipragliflozin (ASP1941), a novel and selective inhibitor of sodium-dependent glucose co-transporter 2, in patients with type 2 diabetes mellitusSherwyn L Schwartz, Bola Akinlade, Sally Klasen, et al.
Pageof 3